Second Round of Gefitinib May Be Promising Lung Cancer Therapy

Patients with non-small cell lung cancer in whom treatment with gefitinib is ineffective often have limited options, but results of a new study suggest that retreating patients with the same drug could have a beneficial effect.
PhysOrg